Print

Alphatec Spine Releases Alphatec NEXoss™ Nanostructure Bio-Active Matrix and Announces the First Patient Implant  
9/18/2012 9:37:29 AM

CARLSBAD, Calif., Sept. 18, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, announced today the first clinical use of Alphatec NEXoss, a next generation synthetic bone graft indicated for use in posterolateral spine fusions in conjunction with bone marrow aspirate, autograft bone and appropriate hardware.
//-->